Searchable abstracts of presentations at key conferences in endocrinology

ea0029p88 | Adrenal cortex | ICEECE2012

Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome

Jochmanova I. , Habalova V. , Wagnerova H. , Lazurova I.

It is well known that primary aldosteronism (PA) is frequently associated with metabolic syndrome. Among possible pathogenic mechanisms, adiponectine gene variants may play a role in the development of metabolic complications especially type two diabetes.Aim of this study was to assess the presence of two single nucleotide polymorphisms of the adiponectin gene (G276T and T45G) in patients with PA and determine their relation to metabolic parameters.<...

ea0026p112 | Female reproduction | ECE2011

Polycystic ovary syndrome and autoimmunity

Petrikova J , Kozakova D , Vrbikova J , Shoenfeld Y , Lazurova I

Polycystic ovary syndrome (PCOS) is characterized by laboratory and/or clinical features consisting of hyperandrogenism with chronic anovulation. and is currently one of the most common endocrinopaties in women of fertile age. PCOS is associated with a variety of endocrine and metabolic disturbances. It is well known that women are more prone to develop autoimmune diseases compared to men and levels of sexual hormones are thought to be responsible for such a difference. Our ai...

ea0026p645 | Clinical case reports | ECE2011

A case of polymyositis and vasculitis induced by ovulation induction therapy with GnRH: case report

Petrikova J , Figurova J , Svajdler M , Lazurova I

Background: GnRH is the first key hormone of reproduction. GnRH analogs are extensively used in IVF, and treatment of sex hormone-dependent cancers due to ability to bring about ‘chemical castration’. Recent studies have demonstrated that GnRH and sex steroids exert not only hormonal effects but play an important role in the immune system modulation.Case report: We report a case of vasculitis and severe polymyositis developed 5 days after GnRH ...

ea0022p553 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Efficacy of acromegaly treatment in six Czech and Slovak tertiary centers: first analysis of patient registry RESET (Registry of Sellar Tumors)

Hana Vaclav , Bandurova L , Brabec P , Cap J , Durovcova V , Hana V , Jarkovska Z , Kentos P , Klapka R , Klimasova K , Klimes D , Krsek M , Lazurova I , Olsovska V , Podoba J , Pura M , Siprova H , Steno J , Sticha M , Trejbalova L , Vanuga P , Wagnerova H , Weiss V , Zeman D , Dusek L , Marek J

Acromegaly is frequently diagnosed late and pituitary macroadenoma is revealed in the majority of patients. Treatment usually needs combination of several treatment modalities to suppress the disease activity. Efficacy of our treatment of acromegaly was not analysed till now.Aim: First analysis of the diagnostics of acromegaly, efficacy of treatment, its complications and status of acromegaly patients in six tertiary referral centers in the Czech Republi...